PLEASANTON, Calif., Nov. 12 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI), a provider of integrated life science systems for microsample preparation and analysis, today announced an $18.1M close of its Series B financing.

SAN DIEGO, July 10 /PRNewswire/ -- Ocera Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of clinical candidates for the treatment of gastrointestinal and liver diseases announced today that it has raised a $12 million Series B financing.

INDIANAPOLIS, Ind., Jan. 17 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., a biopharmaceutical company focused on new therapeutics for neurological diseases, announced a $16.5 million Series A financing.

SAN DIEGO, Jan. 17 /PRNewswire/ -- Ocera Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of clinical candidates for the treatment of gastrointestinal and liver diseases, announced today the completion of a $14.5 million Series A financing.